Silence Therapeutics PLC Notice of AGM (1317G)
June 03 2013 - 6:30AM
UK Regulatory
TIDMSLN
RNS Number : 1317G
Silence Therapeutics PLC
03 June 2013
Notice of General Meeting and Annual Report
03 June 2013
Silence Therapeutics plc (AIM: SLN) announces that its Annual
Report & Accounts for the year ended 31 December 2012 and the
2013 Annual General Meeting (AGM) notice were posted to
shareholders today. The Annual Report & Accounts for the year
ended 31 December 2012 will shortly be available for download at
the Company's website www.silence-therapeutics.com
The 2013 AGM will be held at Silence Therapeutics plc, 3
Shortlands Way, London, W6 8DA on 26 June 2013 at 11.00am.
Silence Therapeutics
Ali Mortazavi, chief executive/Timothy Freeborn, finance
director +44 (0)333 988 0140
a.mortazavi@silence-therapeutics.com
t.freeborn@silence-therapeutics.com
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3000
shaun.dobson@n1singer.com
jenny.wyllie@n1singer.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOASSLFSDFDSEEM
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Nov 2023 to Nov 2024